ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645305 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645305; 2) Community: the network communities that were significantly associated with the response to NSC 645305; 3) Molecule: the relationships between components within communities and NSC 645305; 4) MDR: the compounds that were significantly associated with the NSC 645305.

NSC Compound Enrichment Correlation
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0201565205286438 0.30303964
NSC 735030 Null 0.0201565205286438 0.080115037
NSC 759178 Pipamperone 0.0201565205286438 0.26738335
NSC 763703 (Z)-6-chloro-3-((2-(4-methoxyphenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.0201565205286438 0.076526677
NSC 279836 Mitoxantrone 0.0201565205286441 0.20139798
NSC 361887 1H-Purine-2,6-dione, 8-[3-(dimethylamino)propoxy]-3,7- dihydro-1,3,7-trimethyl-, mixt. with 1,7-dihydro-6H- purine-6-thione 0.0201565205286441 -0.15731297
NSC 46728 Crassin acetate 0.0201565205286441 -0.094394284
NSC 608970 Null 0.0201565205286441 0.00025693705
NSC 641319 5,12-Naphthacenedione, 10-[[3-[[5,5-di(acetyloxy)pentyl]amino]- 2,3,6-trideoxy-.alpha.-L-lyxohexopyranosyl]oxy]- 7,8,9,10-tetrahydro-6,8,11-trihydroxy- 8-(hydroxyacetyl)-1-methoxy-, hydrochloride 0.0201565205286441 0.07041617
NSC 665522 Null 0.0203119150246193 0.063779792
Total:51  Current:22    [First] [Prev] [Next] [Last]